TGFB1 and pulmonary arterial hypertension: Reynolds et al. reported that adenoviral BMPR2 delivery attenuates vascular remodeling in PAH animal models and treatment with BMPR2 ligands ameliorates TGFβ1-induced EndMT in vitro [36].